Brief: Theravance Biopharma Gets Notice From Pfizer Terminating License Agreement
09/06/2023 22:17
June 9 (Reuters) - Pfizer Inc PFE.N :
* THERAVANCE BIOPHARMA INC-GOT NOTICE FROM PFIZER
TERMINATING
LICENSE AGREEMENT FOR PRECLINICAL PAN-JAK INHIBITOR PROGRAM
EFFECTIVE AS OF OCT 7
Further company coverage: PFE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions